| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.4M | -37.8% | -32.6% |
| R&D Expense | $1.2M | -4.5% | +27.5% |
| SG&A Expense | $8.1M | +36.3% | -33.8% |
| Operating Income | -$9.7M | -20.3% | +34.0% |
| Pre-tax Income | -$10.1M | -20.2% | +23.5% |
| Income Tax | -$8K | — | +34.3% |
| Net Income | -$12.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.6M | -48.5% | +125.2% |
| Accounts Receivable | $183K | -70.7% | -70.7% |
| Current Assets | $30.5M | -5.3% | +90.9% |
| Total Assets | $58.8M | -10.1% | +33.0% |
| Current Liabilities | $12.0M | +10.7% | +42.7% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$17.4M | — | — |
| Investing Cash Flow | -$7.7M | — | — |
| Financing Cash Flow | $831K | — | — |
| +8.8% |
| EPS (Basic) | -$0.26 | -44.4% | +36.6% |
| EPS (Diluted) | -$0.26 | -44.4% | +36.6% |
| $43.9M |
| +2.2% |
| +10.3% |
| Stockholders' Equity | $14.9M | -33.7% | +238.2% |